Intermittent high-volume hemofiltration promotes remission in steroid-resistant idiopathic nephrotic syndrome

References

• Erickson FK, Lea J, McClellan WM. Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD. Clin J Am Soc Nephrol. 2013;8(1):75–81
   PubMed Web of Science ®Google Scholar
• Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids – New mechanisms for old drugs. N Engl J Med. 2005;353:1711–1723
   PubMed Web of Science ®Google Scholar
• Ponticelli C, Zucchelli P, Passerini P, Cesana B. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. N Engl J Med. 1992;327(9):599–603
   PubMed Web of Science ®Google Scholar
• Rydel JJ, Korbet SM, Borok RZ, Schwartz MM. Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment. Am J Kidney Dis. 1995;25(4):534–542
   PubMed Web of Science ®Google Scholar
• Chen W, Liu Q, Liao Y, et al. Outcomes of tacrolimus therapy in adults with refractory membranous nephrotic syndrome: a prospective, multicenter clinical trial. Am J Med Sci. 2013;345(2):81–87
   PubMed Web of Science ®Google Scholar
• Gulati A, Sinha A, Jordan SC, et al. Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: Multicentric report. Clin J Am Soc Nephrol. 2010;5(12):2207–2212
   PubMed Web of Science ®Google Scholar
• Aizawa-Yashiro T, Tsuruga K, Watanabe S, Oki E, Ito E, Tanaka H. Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome. Pediatr Nephrol. 2011;26(8):1255–1261
   PubMed Web of Science ®Google Scholar
• Feld SM, Figueroa P, Savin V. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys. Am J Kidney Dis. 1998;32(2):230–237
   PubMed Web of Science ®Google Scholar
• Sato Y, Tsunoda S, Nozue T, Pan Q, Wakasugi H, Yoshimura A. Low-density lipoprotein apheresis therapy for steroid- and cyclosporine-resistant idiopathic membranous nephropathy. Intern Med. 2012;51(18):2597–2602
   PubMed Web of Science ®Google Scholar
• Shalhoub RJ. Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet. 1974;2:556–560
   PubMed Web of Science ®Google Scholar
• Savin VJ, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med. 1996;334:878–883
   PubMed Web of Science ®Google Scholar
• McCarthy ET, Sharma M, Savin VJ. Circulating permaebility factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2011;26(8):1255–1261
   Google Scholar
• Kanai T, Shiraishi H, Yamagata T, et al. Th2 cells predominate in idiopathic steroid-sensitive nephrotic syndrome. Clin Exp Nephrol. 2010;14:578–583
   PubMed Web of Science ®Google Scholar
• Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev. 2008;226:87–102
   PubMed Web of Science ®Google Scholar
• Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–2944
   PubMed Web of Science ®Google Scholar
• Morgera S, Slowinski T, Melzer C, et al. Renal replacement therapy with high-cutoff hemofilters: Impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis. 2004;43:444–453
   PubMed Web of Science ®Google Scholar
• Ratanarat R, Brendolan A, Ricci Z, et al. Pulse high-volume hemofiltration in critically ill patients: a new approach for patients with septic shock. Semin Dial. 2006;19(1):69–74
   PubMed Web of Science ®Google Scholar
• Peng Z, Pai P, Han-Min W, et al. Evaluation of the effects of pulse high-volume hemofiltration in patients with severe sepsis: A preliminary study. Int J Artif Organs. 2010;33(8):505–511
   PubMed Web of Science ®Google Scholar
• Gong D, Zhang P, Ji D, et al. Improvement of immune dysfunction in patients with severe acute pancreatitis by high-volume hemofiltration: A preliminary report. Int J Artif Organs. 2010; 33(1):22–29
   PubMed Web of Science ®Google Scholar
• Souto MF, Teixeira AL, Russo RC, et al. Immune mediators in idiopathic nephrotic syndrome: Evidence for a relation between interleukin 8 and proteinuria. Pediatr Res. 2008;64(6):637–642
   PubMed Web of Science ®Google Scholar
• Ghani RA, Zainudin S, Ctkong N, et al. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume hemofiltration and continous venovenous hemofiltration. Nephrology (Carlton). 2006;11(5):386–393
   PubMed Web of Science ®Google Scholar
• Yu C, Liu ZH, Chen ZH, Ji DX, Li LS. Improvement of monocyte fenction and immune homeostasis by high volume continuous venovenous hemofiltration in patients with severe acute pancreatitis. Int J Artif Organs. 2008;31(10):882–890
   PubMed Web of Science ®Google Scholar
• Tao J, Gong D, Ji D, et al. Improvement of monocyte secretion function in a porcine pancreatitis model by continuous dose dependent veno-venous hemofiltration. Int J Artif Organs. 2008;31(8):716–721
   PubMed Web of Science ®Google Scholar
• Leentjens J, Kox M, Koch RM, et al. Reversal of immunoparalysis in humans in vivo: a double-blind placebo-controlled randomized pilot-study. Am J Respri Crit Care Med. 2012;186(9):838–845
   PubMed Web of Science ®Google Scholar
• Xing CY, Saleem MA, Coward RJ, Ni L, Witherden IR, Mathieson PW. Direct effects of dexamethasone on human podocytes. Kidney Int. 2006;70:1038–1045
   PubMed Web of Science ®Google Scholar
• Garin EH, West L, Zheng W. Effect of interleukin-8 on glomerular sulfated compounds and albuminuria. Pediatr Nephrol. 1997;11(3):274–279
   PubMed Web of Science ®Google Scholar
• Kiliś-Pstrusińska K, Zwolińska D, Medyńska A, Wawro A, Kordecki H. Interleukin-17 concentration in serum and urine of children with idiopathic nephrotic syndrome. Przegl Lek. 2006; 63(Suppl 3):198–200
   PubMedGoogle Scholar
• RC Wiggins. The spectrum of podocytopathies: A unifying view of glomerular disease. Kidney Int. 2007;71:1205–1214
   PubMed Web of Science ®Google Scholar
• Barisoni L, Schnaper HW, Kopp JB. A proposed taxonomy for the podocytopathies: A reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol. 2007;2:529–542
   PubMed Web of Science ®Google Scholar